|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
This article has been cited by other articles:
![]() |
G. Cheng, M. R. Zile, M. Takahashi, C. F. Baicu, D. D. Bonnema, F. Cabral, D. R. Menick, and G. Cooper 4th A direct test of the hypothesis that increased microtubule network density contributes to contractile dysfunction of the hypertrophied heart Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2231 - H2241. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yin, F. Cabral, and S. Veeraraghavan Amino acid substitutions at proline 220 of {beta}-tubulin confer resistance to paclitaxel and colcemid Mol. Cancer Ther., October 1, 2007; 6(10): 2798 - 2806. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang and F. Cabral Heightened Sensitivity to Paclitaxel in Class IVa beta-Tubulin-transfected Cells Is Lost as Expression Increases J. Biol. Chem., September 14, 2007; 282(37): 27058 - 27066. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Arai, Y. Matsumoto, Y. Nagashima, and K. Yagasaki Regulation of Class II {beta}-Tubulin Expression by Tumor Suppressor p53 Protein in Mouse Melanoma Cells in Response to Vinca Alkaloid Mol. Cancer Res., April 1, 2006; 4(4): 247 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hari, F. Loganzo, T. Annable, X. Tan, S. Musto, D. B. Morilla, J. H. Nettles, J. P. Snyder, and L. M. Greenberger Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of {beta}-tubulin (Asp26Glu) and less stable microtubules. Mol. Cancer Ther., February 1, 2006; 5(2): 270 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Ferguson, C. Taylor, A. Stanley, E. Butler, A. Joyce, P. Harnden, P. M. Patel, P. J. Selby, and R. E. Banks Resistance to the Tubulin-Binding Agents in Renal Cell Carcinoma: No Mutations in the Class I {beta}-Tubulin Gene but Changes in Tubulin Isotype Protein Expression Clin. Cancer Res., May 1, 2005; 11(9): 3439 - 3445. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Don, N. M. Verrills, T. Y.E. Liaw, M. L.M. Liu, M. D. Norris, M. Haber, and M. Kavallaris Neuronal-associated microtubule proteins class III {beta}-tubulin and MAP2c in neuroblastoma: Role in resistance to microtubule-targeted drugs Mol. Cancer Ther., September 1, 2004; 3(9): 1137 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Katsetos, A. Legido, E. Perentes, and S. J. Mork Class III {beta}-Tubulin Isotype: A Key Cytoskeletal Protein at the Crossroads of Developmental Neurobiology and Tumor Neuropathology J Child Neurol, December 1, 2003; 18(12): 851 - 866. [Abstract] [PDF] |
||||
![]() |
M. Hari, Y. Wang, S. Veeraraghavan, and F. Cabral Mutations in {alpha}- and {beta}-Tubulin That Stabilize Microtubules and Confer Resistance to Colcemid and Vinblastine Mol. Cancer Ther., July 1, 2002; 2(7): 597 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Barlow, M. L. Gonzalez-Garay, and F. Cabral Paclitaxel-dependent mutants have severely reduced microtubule assembly and reduced tubulin synthesis J. Cell Sci., January 9, 2002; 115(17): 3469 - 3478. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kavallaris, A. S. Tait, B. J. Walsh, L. He, S. B. Horwitz, M. D. Norris, and M. Haber Multiple Microtubule Alterations Are Associated with Vinca Alkaloid Resistance in Human Leukemia Cells Cancer Res., August 1, 2001; 61(15): 5803 - 5809. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Duesberg, R. Stindl, and R. Hehlmann Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy PNAS, December 19, 2000; 97(26): 14295 - 14300. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Montgomery, J. Guzman, D. M. O'Rourke, and W. L. Stahl Expression of Oncogenic Epidermal Growth Factor Receptor Family Kinases Induces Paclitaxel Resistance and Alters beta -Tubulin Isotype Expression J. Biol. Chem., June 2, 2000; 275(23): 17358 - 17363. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||